Expanded Melanocytic Tumour Panel Test
Genetic panel test identifies pathogenic DNA and RNA fusion variants in melanocytic tumours.

Test description

Specific pathogenic variants in BRAF, NRAS,KIT, GNAQ, GNA11 are of diagnostic significance in various melanomas. Fusionsin ALK, ROS1, NTRK, MET and BRAF are seen in Spitzoid neoplasms along with HRAS mutations.

Test information

Test name

Expanded Melanocytic Tumour Panel

Clinical indication

Specific pathogenic variants in BRAF, NRAS, KIT, GNAQ, GNA11 are of diagnostic significance in various melanomas.

Fusions in ALK, ROS1, NTRK, MET and BRAF are seen in Spitzoid neoplasms along with HRAS mutations

Gene(s)

DNA: BRAF, KIT, NRAS, GNAQ, GNA11, HRAS

RNA: ALK fusion, RET fusion, ROS1 fusion, NTRK fusion, MET fusion, BRAF fusion

Method

NGS Oncomine Precision Assay

Turn around time

5 business days from receipt of sample

Medicare eligibility

N/A

Price

DNA only: $425

DNA & RNA: $799

Test request form

Somatic Genetic Testing Request Form

Sample type

FFPE Tumour Tissue

Collection type
Special instructions

6 x 5µm slides plus 1 x H&E-stained slide required